DA
AVNS

Dunvegan Associates’s Avanos Medical AVNS Stock Holding History

Dunvegan Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$17K Sell
495
-13
-3% -$404 0.02% 143
2015
Q3 		$14K Sell
508
-17
-3% -$593 0.02% 149
2015
Q2 		$21K Hold
525
– – 0.02% 131
2015
Q1 		$26K Hold
525
– – 0.02% 135
2014
Q4 		$24K Buy
+525
New +$20.6K 0.02% 134

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dunvegan Associates's AVNS Position: Q4 2015 in Review

Dunvegan Associates reduced its Avanos Medical (AVNS) stake by 2.6% in Q4 2015, selling an estimated $404 and leaving 495 shares worth $17K. The position accounts for 0.02% of the portfolio, ranked #143.

Dunvegan Associates first reported a position in AVNS in Q4 2014 and has held it in 5 quarters since. The position peaked at $26K in Q1 2015. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2015.

  • Dunvegan Associates held 495 shares of Avanos Medical worth $17K as of Q4 2015.
  • Dunvegan Associates sold 13 Avanos Medical shares in Q4 2015, an estimated $404.
  • Avanos Medical made up 0.02% of Dunvegan Associates's portfolio in Q4 2015, its #143 holding.
  • Dunvegan Associates first reported a position in Avanos Medical in Q4 2014 and has held it in 5 quarters since.
  • Dunvegan Associates's Avanos Medical position peaked at $26K in Q1 2015.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.